{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:29:47Z","timestamp":1748971787622},"reference-count":41,"publisher":"Japanese Pharmacological Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Pharmacol. Jpn.","Folia Pharmacologica Japonica"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1254\/fpj.154.275","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T22:25:15Z","timestamp":1573770315000},"page":"275-287","source":"Crossref","is-referenced-by-count":3,"title":["Preclinical pharmacological profiles and clinical efficacy of the novel antipsychotic drug brexpiprazole (REXULTI<sup>\u00ae<\/sup> Tablets 1\u2005mg, 2\u2005mg)"],"prefix":"10.1254","volume":"154","author":[{"given":"Mikio","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of CNS Research, Otsuka Pharmaceutical Co. Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Niidome","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co. Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Lead Discovery Research, Otsuka Pharmaceutical Co. Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Business Division, Otsuka Pharmaceutical Co. Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Usami","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co. Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Futamura","sequence":"additional","affiliation":[{"name":"Department of CNS Research, Otsuka Pharmaceutical Co. Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Newcomer JW. CNS Drugs. 2005;19 Suppl 1:1-93.","DOI":"10.2165\/00023210-200519001-00001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Carlsson A, et al. Pharmacol Rev. 1972;24:371-384.","DOI":"10.1111\/j.1758-6623.1972.tb02346.x"},{"key":"3","unstructured":"3) Kikuchi T, et al. J Pharmacol Exp Ther. 1995;274:329-336."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Stahl SM. J Clin Psychiatry. 2001;62:841-842.","DOI":"10.4088\/JCP.v62n1101"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fleischhacker WW, et al. Expert Opin Pharmacother. 2005;6:2091-2101.","DOI":"10.1517\/14656566.6.12.2091"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Maeda K, et al. J Pharmacol Exp Ther. 2014;350:589-604.","DOI":"10.1124\/jpet.114.213793"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Newman-Tancredi A, et al. Psychopharmacology (Berl). 2011;216:451-473.","DOI":"10.1007\/s00213-011-2247-y"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Meltzer HY. Handb Exp Pharmacol. 2012;212:87-124.","DOI":"10.1007\/978-3-642-25761-2_4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ebdrup BH, et al. Expert Opin Investig Drugs. 2011;20:1211-1223.","DOI":"10.1517\/13543784.2011.601738"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Stahl SM. CNS Spectr. 2009;14:536-546.","DOI":"10.1017\/S1092852900024020"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Correll CU, et al. Am J Psychiatry. 2015;172:870-880.","DOI":"10.1176\/appi.ajp.2015.14101275"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kane JM, et al. Schizophr Res. 2015;164:127-135.","DOI":"10.1016\/j.schres.2015.01.038"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Maeda K, et al. J Pharmacol Exp Ther. 2014;350:605-614.","DOI":"10.1124\/jpet.114.213819"},{"key":"14","unstructured":"15) Inoue T, et al. J Pharmacol Exp Ther. 1996;277:137-143."},{"key":"15","doi-asserted-by":"crossref","unstructured":"16) Amada N, et al. Neuropsychopharmacol Rep. 2019. doi: 10.1002\/npr2.12076.","DOI":"10.1002\/npr2.12076"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Yoshimi N, et al. Eur Neuropsychopharmacol. 2015;25:356-364.","DOI":"10.1016\/j.euroneuro.2014.12.014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) Ishima T, et al. Eur Neuropsychopharmacol. 2015;25:505-511.","DOI":"10.1016\/j.euroneuro.2015.01.014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19) Lieberman JA, et al. Pharmacol Rev. 2008;60:358-403.","DOI":"10.1124\/pr.107.00107"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20) Ishima T, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1656-1659.","DOI":"10.1016\/j.pnpbp.2008.06.011"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21) Ishigooka J, et al. Psychiatry Clin Neurosci. 2018;72:692-700.","DOI":"10.1111\/pcn.12682"},{"key":"21","doi-asserted-by":"crossref","unstructured":"23) Ishigooka J, et al. Psychiatry Clin Neurosci. 2018;72:445-453.","DOI":"10.1111\/pcn.12654"},{"key":"22","unstructured":"24) Fleischhacker WW, et al. Int J Neuropsychopharmacol. 2017;20:11-21."},{"key":"23","doi-asserted-by":"crossref","unstructured":"25) Citrome L, et al. Int Clin Psychopharmacol. 2016;31:192-201.","DOI":"10.1097\/YIC.0000000000000123"},{"key":"24","doi-asserted-by":"crossref","unstructured":"26) Malla A, et al. Int Clin Psychopharmacol. 2016;31:307-314.","DOI":"10.1097\/YIC.0000000000000140"},{"key":"25","doi-asserted-by":"crossref","unstructured":"27) Correll CU, et al. Schizophr Res. 2016;174:82-92.","DOI":"10.1016\/j.schres.2016.04.012"},{"key":"26","doi-asserted-by":"crossref","unstructured":"28) McEvoy J, et al. Clin Schizophr Relat Psychoses. 2016;9:177-186.","DOI":"10.3371\/CSRP.MCCI.010316"},{"key":"27","doi-asserted-by":"crossref","unstructured":"29) Citrome L. Int J Clin Pract. 2015;69:1211-1220.","DOI":"10.1111\/ijcp.12752"},{"key":"28","doi-asserted-by":"crossref","unstructured":"30) Citrome L. Patient Prefer Adherence. 2016;10:1529-1537.","DOI":"10.2147\/PPA.S45401"},{"key":"29","doi-asserted-by":"crossref","unstructured":"31) Leucht S, et al. Lancet. 2013;382:951-962.","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"32) Leucht S, et al. Am J Psychiatry. 2017;174:927-942.","DOI":"10.1176\/appi.ajp.2017.16121358"},{"key":"31","doi-asserted-by":"crossref","unstructured":"33) Citrome L. J Clin Psychopharmacol. 2017;37:138-147. (Suppl. Fig 6.)","DOI":"10.1097\/JCP.0000000000000665"},{"key":"32","unstructured":"36) Zacharias G, et al. Int J Neuropsychopharmacol. 2014;17:823-832."},{"key":"33","doi-asserted-by":"crossref","unstructured":"37) Monti JM, et al. Sleep Med Rev. 2004;8:133-148.","DOI":"10.1016\/S1087-0792(02)00158-2"},{"key":"34","doi-asserted-by":"crossref","unstructured":"38) Yamashita H, et al. Psychiatry Res. 2002;109:137-142.","DOI":"10.1016\/S0165-1781(02)00009-4"},{"key":"35","doi-asserted-by":"crossref","unstructured":"39) Haffmans PM, et al. Br J Psychiatry. 1994;165:697-698.","DOI":"10.1192\/bjp.165.5.697b"},{"key":"36","doi-asserted-by":"crossref","unstructured":"43) Ritsner M, et al. Qual Life Res. 2004;13:783-791.","DOI":"10.1023\/B:QURE.0000021687.18783.d6"},{"key":"37","doi-asserted-by":"crossref","unstructured":"45) Iqbal N, et al. CNS Spectr. 2007;12(9 Suppl. 14):1-16.","DOI":"10.1017\/S1092852900026201"},{"key":"38","doi-asserted-by":"crossref","unstructured":"49) Results of Expert Consensus Survey on Adherence 2008. J Clin Psychiatry 2009;70(suppl 4):1-37.","DOI":"10.4088\/JCP.7090su1cj.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"50) Kroeze WK, et al. Neuropsychopharmacology. 2003;28:519-526.","DOI":"10.1038\/sj.npp.1300027"},{"key":"40","doi-asserted-by":"crossref","unstructured":"51) Matsui-Sakata A, et al. Drug Metab Pharmacokinet. 2005;20:368-378.","DOI":"10.2133\/dmpk.20.368"},{"key":"41","doi-asserted-by":"crossref","unstructured":"52) Yoshimi N, et al. Pharmacol Biochem Behav. 2014;124:245-249.","DOI":"10.1016\/j.pbb.2014.06.008"}],"container-title":["Folia Pharmacologica Japonica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/154\/5\/154_275\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T07:46:52Z","timestamp":1664956012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/154\/5\/154_275\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1254\/fpj.154.275","relation":{},"ISSN":["0015-5691","1347-8397"],"issn-type":[{"value":"0015-5691","type":"print"},{"value":"1347-8397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}